National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 370602

Government Disclaimer on use of this data

Case Details

VAERS ID: 370602 (history)  
Form: Version 1.0  
Sex: Male  
Location: Foreign  
Submitted: 2009-11-30
Entered: 2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Drug exposure during pregnancy, Premature baby
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Neonatal disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Folic acid
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data: UNK
CDC Split Type: B0563470B

Write-up: This prospective pregnancy case was reported by a nurse practitioner and described the occurrence of premature birth in male neonate exposed to CERVARIX transplacentally when his mother was being vaccinated with CERVARIX. The neonate was also exposed to Folic acid transplacentally, which the mother took concurrently. On 09 January 2009, the 17-year-old mother of the patient received a dose of CERVARIX (1 injection, intramuscular, left deltoid). The mother''s last menstrual period was on 21 December 2008 and estimated date of delivery was on 27 September 2009. The neonate was exposed to CERVARIX during the first trimester. On 21 August 2009, at 34 weeks gestation, the neonate was delivered by normal vaginal delivery and weighed 2.1 kg (head circumference 32 cm). The neonate was born pre-term at 34 weeks gestation and experienced a premature birth. No birth defects were noted. It was reported that "there was no details from the hospital regarding treatment following delivery" and that the neonate was in SCBU". The neonate was hospitalised. At the time of reporting the baby was "12 weeks old and healthy with no obvious problems". The reporting nurse practitioner did not provide a causal relationship between the event and the mother''s treatment with CERVARIX. Please see report B0563470A for details regarding the mother case.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166